
Covance Not Cooling...


| Price and Volume | |
|---|---|
| Recent Price | 0.66 |
| 52 Week High | 2.78 |
| 52 Week Low | 0.63 |
| Avg. Daily Vol. (Mil) | 0.07 |
| Beta (3 year) | 1.80 |
| Share Related Items | |
| Mkt Cap (Mil) | 8.55 |
| Shares Out (Mil) | 12.95 |
| Float (Mil) | 12.89 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.90 |
| Current Ratio | 4.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.16 |
| Price/Book | 0.77 |
| Price/Cash Flow | -0.40 |
| Per Share Data | |
| Earnings | -1.08 |
| Sales | 0.57 |
| Book Value | 0.85 |
| Cash Flow | -1.59 |
| Business Summary | |
|---|---|
| Genvec, Inc. is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. | |
| General Information | |
| 65 West Watkins Mill Road
Gaithersburg, MD 20878 |
|
| www.genvec.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 44 | |
| CEO: Ms. Cynthia Collins | |
| Short Interest | |
| Current Month (Mil) | 0.01 |
| Previous Month (Mil) | 0.01 |
| Short Interest Ratio (Days) | 0.30 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -145.80 |
| Return on Investments | -188.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |